Poster to be presented at American College of Rheumatology Convergence 2025 –BRISBANE, Calif., (GLOBE NEWSWIRE) -- Pacira ...
2h
AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for "Bubble Baby Disease"
AGC Biologics, your friendly CDMO expert, announced an agreement to provide comprehensive development and manufacturing for Rarity PBC's gene therapy.
Opportunities in viral vector manufacturing arise from rising demand for GMP-grade materials and increasing gene therapy ...
Zacks Investment Research on MSN
REGN Reports Encouraging Data on Gene Therapy for Genetic Hearing Loss (Revised)
Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study.
“Beyond UniQure, the pipeline includes highly promising approaches that will ideally move the goal from merely managing ...
Rocket Pharmaceuticals (NASDAQ:RCKT) added ~11% in the premarket on Tuesday after the company announced that the FDA had ...
ALAMEDA, Calif., April 30, 2025 /PRNewswire/ -- CellFE, a leader in non-viral gene editing technology, today announced a strategic collaboration with the Harbottle Lab at German Cancer Research Center ...
LONDON, GREATER LONDON, UNITED KINGDOM, October 15, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...
CHICAGO--(BUSINESS WIRE)--Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in gene delivery solutions, announced a strategic partnership to ...
Thermo Fisher will equip Dr. Park CDMO’s new facility with advanced bioreactors to scale viral vector manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback